中國奧園(03883.HK)就奧園美谷擬轉讓股權事項指定深圳凱弦為投標人
格隆匯7月9日丨中國奧園(03883.HK)公吿,就此前,奧園美谷擬轉讓多家公司股權以專注綠纖新材料業務和醫療美容業務。公司已指定深圳市凱弦投資有限責任公司("深圳凱弦")為投標人,以參與公開招標及向北交所提交投標申請。深圳凱弦為公司間接全資附屬公司,主要從事投資控股。
公司正在優化其組織架構並推進戰略實施。預期於深圳凱弦成功投標目標附屬公司股權及完成公開招標後:(i)僅有目標附屬公司的若干中間股東會出現變動,而公司於目標附屬公司間接持有的最終股權將維持不變;及(ii)奧園美谷及其附屬公司將專注於醫療美容業務,而公司其他附屬公司則繼續主要專注於物業發展及投資。
公開招標的結果預期於2021年7月14日或前後公佈。於公吿日期,公司並無訂立任何有關目標附屬公司正式股權轉讓協議。公司將根據上市規則於適當時候另行刊發公吿,以知會股東及潛在投資者有關公開招標進展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.